MCRB – seres therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MCRB

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/14

11:10 am

mcrb

Rating for MCRB

Low Report

Rating for MCRB

Report

11/13

07:42 pm

mcrb

Seres Therapeutics, Inc. (NASDAQ: MCRB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $1.25 price target on the stock.

Low Report

Seres Therapeutics, Inc. (NASDAQ: MCRB) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $1.25 price target on the stock.

Report

11/13

06:55 pm

mcrb

Rating for MCRB

Low Report

Rating for MCRB

Report

10/24

07:16 am

mcrb

Seres Therapeutics, Inc. (NASDAQ: MCRB) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.

Medium Report

Seres Therapeutics, Inc. (NASDAQ: MCRB) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.

Report

10/24

07:06 am

mcrb

Rating for MCRB

Medium Report

Rating for MCRB

Report

9/13

02:36 pm

mcrb

Rating for MCRB

Low Report

Rating for MCRB

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.